Getting tested for mesothelioma involves a series of steps, starting with imaging scans and ending with a tissue biopsy that confirms the diagnosis under a microscope. No single test can diagnose mesothelioma on its own. The process typically begins with your primary care doctor or a pulmonologist and moves through increasingly specific tests over the course of several weeks.
Why Mesothelioma Is Hard to Detect Early
Mesothelioma symptoms overlap heavily with more common conditions. Shortness of breath, chest pain, persistent cough, and unexplained fluid buildup around the lungs can all point to pneumonia, heart failure, or other lung diseases. The cancer also has a long latency period, often appearing 20 to 50 years after asbestos exposure, which means many patients and even their doctors don’t immediately suspect it.
If you have a known history of asbestos exposure and develop new respiratory symptoms, make that history clear to your doctor from the start. It changes the urgency and direction of the workup significantly.
Imaging: The First Step
A chest X-ray is almost always the first test ordered. It can reveal a unilateral pleural effusion (fluid on one side of the chest), which shows up in 30% to 80% of mesothelioma patients at presentation. It may also show diffuse pleural thickening or lobular masses along the lining of the lung, visible in roughly half of cases. However, X-ray findings are nonspecific. Fluid around the lungs has dozens of possible causes, so an abnormal X-ray alone only raises suspicion.
A CT scan is the core imaging tool. CT detects pleural thickening in 90% to 92% of mesothelioma patients and picks up pleural effusions in about 75% of cases. It gives a much clearer picture of where thickening or masses are located, how extensive they are, and whether nearby structures look involved. Your doctor will use the CT scan to decide what kind of biopsy to perform and where to target it.
Ultrasound sometimes plays a supporting role, particularly for evaluating how much fluid has collected and guiding a needle to drain it. On ultrasound, mesothelioma tends to appear as irregular, partly angular growths with unclear borders, sometimes with nodules scattered across the pleural surface.
Fluid Drainage and Analysis
If you have significant fluid buildup around the lung, your doctor will likely drain some of it with a needle (a procedure called thoracentesis). This serves two purposes: it relieves pressure so you can breathe more easily, and it sends fluid to the lab for analysis.
Pathologists examine the fluid for abnormal cells. However, distinguishing mesothelioma cells from other cancers or even from reactive, non-cancerous cells in fluid alone is extremely difficult. Fluid analysis can sometimes suggest mesothelioma, but it rarely provides a definitive diagnosis. A tissue biopsy is almost always needed to confirm.
Biopsy: The Only Way to Confirm
A tissue biopsy is the definitive test. There are two main approaches, and both have comparable accuracy with low complication rates.
- CT-guided needle biopsy: A radiologist uses CT imaging to guide a needle through the chest wall into the thickened pleura or a mass. You’re awake with local anesthesia. It’s the least invasive option and works well when there’s a clear target on the scan.
- Thoracoscopy: A small camera is inserted through a small incision in the chest wall, allowing the doctor to directly see the pleural surface and take larger tissue samples. This can be done under local anesthesia by a pulmonologist (medical thoracoscopy) or under general anesthesia by a surgeon (video-assisted thoracoscopic surgery, or VATS). Thoracoscopy is particularly useful when needle biopsy results are inconclusive or when the doctor wants to visually assess how far the disease has spread along the pleural lining.
Local anesthetic thoracoscopy has become increasingly popular because it matches the diagnostic accuracy of VATS without requiring general anesthesia, which means a faster recovery.
How Pathologists Confirm the Diagnosis
Once tissue is collected, the real diagnostic work happens in the pathology lab. Mesothelioma can look strikingly similar to lung adenocarcinoma and other cancers that spread to the pleural lining, so pathologists run a panel of special stains called immunohistochemistry to tell them apart.
The most important marker is calretinin. In studies comparing mesothelioma to lung adenocarcinoma, calretinin was positive in 100% of mesothelioma cases and negative in nearly all adenocarcinoma cases. Pathologists also look for markers that are typically positive in lung cancer but absent in mesothelioma. A marker called TTF-1, for instance, was positive in about 62% of adenocarcinoma patients but negative in 100% of mesothelioma patients in one study. CEA and CK7 follow a similar pattern, lighting up in adenocarcinoma but staying dark in mesothelioma.
This panel approach, combining markers that are positive in mesothelioma with markers that are negative, gives pathologists high accuracy in distinguishing it from other cancers. The process typically takes at least a few days after the biopsy, though complex cases sent for second opinions at specialized centers can take longer.
Blood Tests: Helpful but Not Definitive
A blood test called the MESOMARK assay measures levels of a protein called soluble mesothelin-related peptide (SMRP) that mesothelioma cells release into the bloodstream. In studies, SMRP levels were elevated in 52% of mesothelioma patients compared to only 5% of people with asbestos exposure but no cancer.
Those numbers highlight both the promise and the limitation: the test misses about half of mesothelioma cases. It’s more useful for monitoring disease progression in patients already diagnosed than for catching the cancer in the first place. A normal SMRP level does not rule out mesothelioma, and an elevated level doesn’t confirm it.
Staging Scans After Diagnosis
Once mesothelioma is confirmed, additional imaging determines how far it has spread. This matters for treatment planning.
PET/CT scans combine metabolic and anatomical information. Mesothelioma tumors take up the radioactive tracer used in PET scans at significantly higher rates than benign pleural disease, with one study reporting 91% sensitivity and 100% specificity. PET/CT is particularly valuable for detecting cancer in lymph nodes and distant organs that may look normal on a standard CT. It has also caught hidden metastases in patients who were otherwise being considered for surgery.
MRI is reserved for specific questions. It’s better than CT at showing whether the tumor has grown through the diaphragm into the abdomen or invaded the chest wall. Surgeons often request an MRI when they’re evaluating whether an operation is feasible.
Testing for Peritoneal Mesothelioma
Mesothelioma can also develop in the lining of the abdomen (the peritoneum), and the diagnostic path looks somewhat different. CT imaging typically reveals a soft tissue mass with irregular margins, along with fluid in the abdomen (ascites), thickening of the omentum (the fatty tissue draping over the intestines), and nodular growths on the peritoneal surface.
The blood marker CA-125 is sometimes elevated in peritoneal mesothelioma, but it’s nonspecific and has limited diagnostic value on its own since it can be raised in ovarian cancer and other conditions.
Definitive diagnosis requires tissue, obtained either through a CT-guided core needle biopsy or through diagnostic laparoscopy, where a surgeon inserts a camera through a small abdominal incision. Laparoscopy allows the surgeon to directly visualize the peritoneal surface and take biopsies from multiple sites. The tissue then undergoes the same immunohistochemistry panel used for pleural mesothelioma, with markers like D2-40 and cytokeratin AE1/AE3 helping confirm the diagnosis.
Which Doctors Handle This Workup
The diagnostic process often starts with a primary care physician or pulmonologist, but mesothelioma is rare enough that you’ll want specialists involved early. A thoracic surgeon or cardiothoracic surgeon typically performs or coordinates the biopsy. A medical oncologist takes over once the diagnosis is confirmed, and a radiologist with experience reading mesothelioma scans is essential for accurate staging.
Because mesothelioma is uncommon (roughly 3,000 new cases per year in the United States), many community hospitals see very few cases. Major cancer centers and National Cancer Institute-designated facilities tend to have multidisciplinary teams with more experience interpreting biopsies, reading scans, and coordinating treatment. If your initial biopsy results are ambiguous or your local pathologist is uncertain, requesting a second opinion at a high-volume center is reasonable and common. Pathology slides can be shipped without requiring you to repeat the biopsy.